Page last updated: 2024-08-21

hesperidin and Apoplexy

hesperidin has been researched along with Apoplexy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, L; Liu, M; Qin, Z; Tan, H; Zheng, L	1

Trials

1 trial(s) available for hesperidin and Apoplexy

Article	Year
Hesperidin reduces adverse symptomatic intracerebral hemorrhage by promoting TGF-β1 for treating ischemic stroke using tissue plasminogen activator. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2020, Volume: 41, Issue:1 Topics: Aged; Biomarkers; Brain Ischemia; Cerebral Hemorrhage; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Hesperidin; Humans; Male; Middle Aged; Stroke; Tissue Plasminogen Activator; Transforming Growth Factor beta1; Treatment Outcome	2020

Article

Year

Hesperidin reduces adverse symptomatic intracerebral hemorrhage by promoting TGF-β1 for treating ischemic stroke using tissue plasminogen activator.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2020, Volume: 41, Issue:1

Topics: Aged; Biomarkers; Brain Ischemia; Cerebral Hemorrhage; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Hesperidin; Humans; Male; Middle Aged; Stroke; Tissue Plasminogen Activator; Transforming Growth Factor beta1; Treatment Outcome

2020